Hippocratic AI Unicorn Score: 86/100
Hippocratic AI develops a safety-focused generative AI healthcare agent designed for health systems, payors, and pharmaceutical companies. The platform leverages extensive clinical interactions to provide reliable AI assistance, aiming to address the global shortage of healthcare workers and improve patient outcomes.
Valuation track record
- First screened
- May 24, 2026
- Entry valuation
- $3.5B
- Current valuation
- $3.5B
Latest valuation verified from Live re-screening on May 24, 2026. Re-verified quarterly from public funding announcements.
Founders
Get the full Hippocratic AI report
Founders deep-dive, traction signals, market thesis, red flags, scoring breakdown and an audio summary, delivered to your inbox.
Frequently asked
What is Hippocratic AI's unicorn score?
Hippocratic AI has a Unicorn Screener score of 86/100, classified as "High Potential". Recommended action: buy.
What is Hippocratic AI's current valuation?
Hippocratic AI's most recently verified valuation is $3.5B, last checked on May 24, 2026 (source: Live re-screening).
What sector is Hippocratic AI in?
Hippocratic AI operates in the HealthTech sector and is headquartered in Palo Alto, United States.
When was Hippocratic AI first screened?
Hippocratic AI was first screened by Unicorn Screener on May 24, 2026, with an entry valuation of $3.5B.